Supriya Lifescience Limited Sustainability Profile
Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
DitchCarbon Score
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Supriya Lifescience Limited's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Supriya Lifescience Limited's reported carbon emissions
In 2024, Supriya Lifescience Limited reported significant carbon emissions, with Scope 1 emissions totalling approximately 16,125,000 kg CO2e and Scope 2 emissions reaching about 66,760,000 kg CO2e in India. This reflects a notable increase from 2023, where Scope 1 emissions were around 13,842,000 kg CO2e and Scope 2 emissions were approximately 74,188,000 kg CO2e. Globally, in 2024, the company recorded Scope 1 emissions of about 451,010 kg CO2e and Scope 2 emissions of approximately 10,995,310 kg CO2e. The emissions data indicates a consistent disclosure of Scope 1 and Scope 2 emissions, while Scope 3 emissions have not been reported. Despite the lack of specific reduction targets or initiatives, Supriya Lifescience Limited is committed to monitoring and managing its carbon footprint. The company has not set Science-Based Targets Initiative (SBTi) reduction targets or documented any climate pledges, indicating an opportunity for future commitments in line with industry standards. Overall, Supriya Lifescience Limited's emissions data highlights the need for enhanced climate strategies to address its carbon footprint effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 315,257 | 000,000 | 000,000 |
| Scope 2 | 8,643,810 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Supriya Lifescience Limited's Industry?
How Carbon Intensive is Supriya Lifescience Limited's Location?
Supriya Lifescience Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Supriya Lifescience Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
